Roche says Lucentis 'port' system as good as injections in eye disease
Roche said a new port delivery system (PDS) for its eye drug Lucentis was as good as monthly injections in blindness-causing macular degeneration, as the Swiss drugmaker aims to refresh its older blockbuster medicine as new rivals press in.
from Reuters: Health News https://reut.rs/2ZC04wt
https://bit.ly/2zwRqiM
May 26, 2020
|
Labels:
health,
Reuters: Health News
|
This entry was posted on May 26, 2020
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.